Purchase 2-MCF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 2-MCF for sale
2-Methyl-maf is a designer drug developed in Japan by the pharmaceutical company Daiichi Sankyo. It has structural and pharmacological properties similar to methcathinone but with higher potency, reduced metabolism from liver enzymes, increased bioavailability and longer acting.
2-mcf is a designer drug developed in Japan by the pharmaceutical company Daiichi Sankyo. It has structural and pharmacological properties similar to methcathinone but with higher potency, reduced metabolism from liver enzymes, increased bioavailability and longer acting. In rats, 2-MCF produces conditioned place preference at doses of 5-10 mg/kg and locomotor stimulation at doses of 10-30 mg/kg.
2-MCF is a designer drug that is orally administered to rats, and 2-MCF can be a potential treatment option for Parkinson's disease.
Daiichi Sankyo, a Japanese pharmaceutical company, developed a designer drug known as 2-Methylcathinone, a Cathinone derivative. 2-Methylcathinone is known to produce desired effects such as increased energy and alertness. If you are looking for this designer drug, visit us at our online shop. We have the safest and most effective designer drugs you can find on the market today.
2-Methylmethcathinone(also known as 2-methyl-MAF,bk-MBDB, bk-MBDP, bk-MDMA, MCR) is a designer drug that acts as a substituted cathinone (a type of stimulant). Its chemical name is bk-MCAT, and its IUPAC name is 2-(methylamino)-1-(methylamino)-1-phenylbutazone-1-one. Its chemical formula is C12H15NO2 and it is structurally derived from Cathinone.
Synthetic stimulants all have slightly different effects; however, they all tend to be powerful and highly addictive.
2-MCF is a synthetic cathinone with stimulant and entactogenic effects. It acts as a unique stimulant with the potential for abuse. Although 2-mcf does not cause the euphoria associated with other CNS stimulants, it offers users a mood boost, increased energy and motivation, so it is sometimes used as a short-term energy supplement by people who need extra alertness during night shifts or other demanding situations.
2-mcf is a synthetic cathinone with stimulant and entactogenic effects. This means it can be abused by people who need extra alertness during work or night shifts. It also makes people feel more energetic and motivated.
2-Methcathinone, also known as 2-Methylpropionone or 2-MC, is a synthetic stimulant drug similar to amphetamine. It was developed in the early 1930s as a potential replacement for amphetamine and eventually used to produce nasal decongestants, energy drinks, and some over-the-counter supplements.
2-Methylmethcathinone (2-MMC) is a synthetic drug that acts as a stimulating agent. It has some entactogenic qualities and may be illegal in certain countries.
2-Methylenedioxypyrovalerone is a chemical substance of the phenethylamine chemical class which acts as a stimulant and entactogen. As an NPS, it was first reported in 2013 in the United States.
2-MCF resembles a common legal compound; however, its pharmacological effects have been speculated to be stronger. It also comes in a powder form that can be snorted and ingested, making it more versatile than its predecessor.
2-MCF is a new formula of synthetic marijuana closely trended to JWH-018. Also sold in a powdery form, this drug has rapidly gained popularity among medical marijuana users around the world.
Chemical analysis indicates that 2-MCF shares many characteristics with common narcotic drugs but has an increased potential for addiction.
2-MCF is a designer drug developed in Japan by the pharmaceutical company Daiichi Sankyo.
2-mcf is not a scheduled drug in most countries, but it can be considered similar to MDPV and methcathinone. 2-MCF has similar effects to 2-MeMABP and mephedrone but with more potency and less nausea. It can also be used as a replacement for 2C-B, but with much fewer side effects and very little memory loss compared to the latter.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
1kg $1890
1kg $1590
1kg $1690
out of stock
300g $970
100g $690
500g $1080
1kg $1690
1kg $1590
100g $580
1kg $1590
1kg $1590